Feng LS, Li HY, Tang A, Xu ML, et al. Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia. Int J Hematol 2025 Jan 23. doi: 10.1007/s12185-025-03915.
PMID: 39847198